Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk

Kaohsiung Journal of Medical Sciences

Volumn 28, Issue 3, 2012, Pages 151-160

  Wang, Chia Chi ^a   Tseng, Tai Chung ^a   Hsieh, Tsung Cheng ^a   Hsu, Ching Sheng ^a   Wang, Pin Chao ^a   Lin, Hans Hsienhong ^a   Kao, Jia Horng ^b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cardiovascular disease; Diabetes mellitus; Metabolic syndrome; Non alcoholic fatty liver disease (NAFLD); Ultrasound

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; FRAMINGHAM RISK SCORE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; OBESITY; PREVALENCE; WAIST CIRCUMFERENCE;

ADULT; CARDIOVASCULAR DISEASES; FATTY LIVER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 84862794098     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2011.10.005     Document Type: Article

References (47)

1. C.H. Chiang, C.C. Huang, W.L. Chan, J.W. Chen, and H.B. Leu The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population Clin Biochem 43 2010 1399 1404
2. C.F. Kuo, K.H. Yu, S.F. Luo, C.T. Chiu, Y.S. Ko, and J.S. Hwang Gout and risk of non-alcoholic fatty liver disease Scand J Rheumatol 39 2010 466 471
3. C.H. Chen, C.K. Nien, C.C. Yang, and Y.H. Yeh Association between nonalcoholic fatty liver disease and coronary artery calcification Dig Dis Sci 55 2010 1752 1760
4. M.H. Hsieh, C.K. Ho, N.J. Hou, M.Y. Hsieh, W.Y. Lin, and J.F. Yang Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C Int J Obes (Lond) 33 2009 1309 1317
5. C.C. Wang, S.K. Lin, Y.F. Tseng, C.S. Hsu, T.C. Tseng, and H.H. Lin Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease J Gastroenterol Hepatol 24 2009 1411 1416
6. C.H. Tsai, T.C. Li, and C.C. Lin Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease South Med J. 101 2008 900 905
7. C.J. Chu, R.H. Lu, S.S. Wang, F.Y. Chang, S.L. Wu, and C.L. Lu Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha Hepatogastroenterology 54 2007 2099 2102
8. H.L. Huang, W.Y. Lin, L.T. Lee, H.H. Wang, W.J. Lee, and K.C. Huang Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects Obes Surg 17 2007 1457 1463
9. P.J. Hsiao, K.K. Kuo, S.J. Shin, Y.H. Yang, W.Y. Lin, and J.F. Yang Significant correlations between severe fatty liver and risk factors for metabolic syndrome J Gastroenterol Hepatol 22 2007 2118 2123
10. C.H. Chen, M.H. Huang, J.C. Yang, C.K. Nien, C.C. Yang, and Y.H. Yeh Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan J Gastroenterol Hepatol 22 2007 1482 1489
11. C.H. Chen, M.H. Huang, J.C. Yang, C.K. Nien, C.C. Yang, and Y.H. Yeh Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults J Clin Gastroenterol 40 2006 745 752
12. S. Chitturi, G.C. Farrell, and J. George Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? J Gastroenterol Hepatol 19 2004 368 374 (Pubitemid 38570185)
13. J.B. Dixon, P.S. Bhathal, and P.E. O'Brien Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 2001 91 100 (Pubitemid 32591518)
14. S. Jimba, T. Nakagami, M. Takahashi, T. Wakamatsu, and Y. Hirota Lwamotot Yand Wasada. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults Diabet Med 22 2005 1141 1145 (Pubitemid 41224170)
15. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
16. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Bopapai, Y.C. Liu, and A. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419 (Pubitemid 29258890)
17. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, and C.J. Driscoll Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669 (Pubitemid 29109578)
18. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, and W. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80 (Pubitemid 20075105)
19. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, and M. Lenzi Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850 (Pubitemid 33641605)
20. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, and R. Manini Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome Hepatology 37 2003 917 923 (Pubitemid 36397405)
21. N.D. Wong Metabolic syndrome: cardiovascular risk assessment and management Am J Cardiovasc Drugs 7 2007 259 272 (Pubitemid 47295836)
22. H. Cortez-Pinto, M.E. Camilo, A. Baptista, and A. Oiveira Moura MC De. Nonalcoholic fatty liver: another clinical feature of the metabolic syndrome? Clin Nutr 18 1999 353 358 (Pubitemid 30032243)
23. G. Targher, L. Bertolini, F. Poli, S. Rodella, C. Scala, and R. Tessari Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients Diabetes 54 2005 3541 3546 (Pubitemid 43334347)
24. G. Targher, L. Bertolini, R. Padovani, F. Poli, L. Scala, and R. Tessari Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease Diabet Med 23 2006 403 409
25. G. Targher, and G. Arcaro Non-alcoholic fatty liver disease and increased risk of cardiovascular disease Atherosclerosis 191 2007 235 240 (Pubitemid 46400718)
26. L.A. Adams, J. Lymp, J. St Sauver, S.O. Sanderson, K.D. Lindor, and A. Feldstein The natural history of nonalcoholic fatty liver disease: a population based cohort study Gastroenterology 129 2005 113 121 (Pubitemid 41002048)
27. B. Maharaj, R.J. Maharaj, W.P. Leary, R.M. Cooppan, A.D. Naran, and D. Pirie Sampling variabilty and its Influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 1986 523 525 (Pubitemid 16138427)
28. T. Poynard, V. Ratziu, and P. Bedossa Appropriateness of liver biopsy Can J Gastroenterol 14 2000 543 548 (Pubitemid 30447225)
29. P. Cals, F. Lainé, J. Boursier, Y. Deugnier, V. Moal, and F. Oberti Comparison of blood tests for liver fibrosis specific or not to NAFLD J Hepatol. 50 2009 165 173
30. S. McPherson, S.F. Stewart, E. Henderson, A.D. Burt, and C.P. Day Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease Gut 59 2010 1265 1269
31. M. Hamaguchi, T. Kojima, Y. Itoh, Y. Harano, T. Fujii, and T. Nakajima The severity of ultrasound findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation Am J Gastroenterol 102 2007 2708 2715 (Pubitemid 350179336)
32. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
33. C.M. Rumack, S.R. Wilson, and J.W. Charboneau Diagnostic ultrasound 2nd ed. 1998 Mosby St. Louis, MO 110-112
34. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847 (Pubitemid 28213628)
35. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, and H.S. Conjeevaram A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526 (Pubitemid 36919874)
36. D. Prati, E. Taioli, A. Zanella, E. Della Torre, S. Butelli, and E. Del Vecchio Updated definitions of healthy ranges for serum alanine aminotransferase levels Ann Intern Med 137 2002 1 10
37. G. Celle, V. Savarino, A. Picciotto, M.R. Magnolia, P. Scalabrini, and M. Dodero Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques Dig Dis Soc 33 1988 467 471
38. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, and M. Hurley The utility of radiographic imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750 (Pubitemid 34977081)
39. A. Brea, D. Mosquera, E. Martin, A. Arizti, J.L. Cordero, and E. Ros Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study Arterioscler Thromb Vasc Biol 25 2005 1045 1050 (Pubitemid 40627853)
40. G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Zoppini, and L. Zenari Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease Diabetes Care 29 2006 1325 1330 (Pubitemid 44125930)
41. A. Santoliquido, C. Di Campli, L. Miele, M.L. Gabrieli, A. Forgione, and M.A. Zocco Hepatic steatosis and vascular disease Eur Rev Med Pharmacol Sci 9 2005 269 271 (Pubitemid 41387390)
42. J.M. Clark, F.L. Brancati, and A.M. Diehl The prevalence and etiology of elevated aminotransferase levels in the United States Am J Gastroenterol 98 2003 960 967 (Pubitemid 36733754)
43. C.P. Day, and O.F. James Steatohepatitis: a tale of two ''hits''? Gastroenterology 114 1998 842 845
44. C.C. Wang, W.W. Wu, C.S. Hsu, P.C. Wang, H.H. Lin, and J.H. Kao Association of insulin resistance with alanine aminotransferase activity in patients with nonalcoholic fatty liver disease Tzu Chi Medical Journal 4 2008 275 279
45. A.A. Shaheen, and R.P. Myers Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review Hepatology 46 2007 912 921 (Pubitemid 47436137)
46. C.H. Liu, C.C. Liang, C.J. Liu, S.J. Hsu, J.W. Lin, and S.I. Chen The ratio of alanine aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C Kidney Int 78 2010 103 109
47. A. Loaeza-del-Castillo, F. Paz-Pineda, E. Oviedo-Cárdenas, F. Sanchez-Avila, and F. Vargas-Vorackova AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis Ann Hepatol 7 2008 350 357